Quest Diagnostics DGX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 132.7%+1.5pp | 132.4%+1.1pp | 132%+0.6pp | 131.5%-0.3pp | 131.2%-1.3pp | |
| Operating margin | 56.5%+2.5pp | 55.9%+2.1pp | 55.5%+1.6pp | 54.5%+1.6pp | 54%+2.2pp | |
| Net margin | 36%+0.6pp | 35.8%0.0pp | 35.6%-0.5pp | 35.5%0.0pp | 35.5%+0.5pp | |
| EBITDA margin | 77.1%+3.3pp | 76.5%+3.1pp | 75.9%+2.7pp | 74.6%+2.6pp | 73.8%+3.0pp | |
| Free cash flow margin | 48.5%+8.9pp | 47.2%+7.7pp | 44.1%+4.5pp | 42%+6.7pp | 39.7%+4.5pp | |
| Returns | ||||||
| Return on equity | 56.1%+3.5pp | 55.2%+2.5pp | 54.2%+0.9pp | 53.2%+0.5pp | 52.5%+0.4pp | |
| Return on assets | 24.8%+1.2pp | 24.5%+0.6pp | 24.2%-0.4pp | 23.9%-0.7pp | 23.6%-0.7pp | |
| Return on invested capital | 36.3%+2.2pp | 35.9%+1.6pp | 35.4%+0.4pp | 34.6%-0.8pp | 34.1%-1.3pp | |
| Efficiency | ||||||
| Asset turnover | 2.8×+0.1× | 2.7×+0.1× | 2.7×0.0× | 2.7×-0.1× | 2.7×-0.1× | |
| Inventory turnover | 152.8×+11.7× | 153.3×+15.4× | 149.3×+14.0× | 145×+10.7× | 141.1×+7.2× | |
| Liquidity | ||||||
| Current ratio | 4.4×-0.4× | 4.7×+0.4× | 4.8×+0.2× | 4.9×+0.5× | 4.8×+0.5× | |
| Quick ratio | 4.1×-0.3× | 4.3×+0.3× | 4.4×+0.2× | 4.5×+0.5× | 4.4×+0.5× | |
| Cash ratio | 0.7×-0.2× | 0.7×-0.3× | 0.7×-0.3× | 0.9×+0.1× | 0.9×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 3.5×-0.2× | 3.6×0.0× | 3.7×+0.3× | 3.9×+0.7× | 3.8×+0.5× | |
| Debt-to-assets | 1.6×-0.1× | 1.6×0.0× | 1.6×+0.1× | 1.7×+0.2× | 1.6×+0.1× | |
| Net debt / EBITDA | 11.4×-1.8× | 12×-0.7× | 12.7×+0.6× | 13.4×+2.0× | 13.2×+1.6× | |
| Valuation | ||||||
| Market capitalization | $82.23B+20.7% | $79.48B+24.1% | $77.01B+22.8% | $72.98B+23.4% | $68.1B+14.2% | |
| Enterprise value | $106.24B+15.6% | $103.86B+20.3% | $101.8B+22.2% | $98.03B+25.2% | $91.9B+16.6% | |
| Price / earnings | 83.6×+4.7× | 83.5×+8.1× | 83.4×+9.2× | 82×+10.4× | 78.9×+5.6× | |
| Price / sales | 7.5×+0.5× | 7.5×+0.7× | 7.4×+0.7× | 7.3×+0.9× | 7×+0.6× | |
| Price / book | 11.3×+1.3× | 11.1×+1.5× | 10.9×+1.3× | 10.5×+1.3× | 10×+0.6× | |
| EV / EBITDA | 50.5×-0.6× | 51.1×+1.6× | 51.8×+3.1× | 52.4×+5.7× | 51.1×+3.4× | |
| EV / sales | 9.7×+0.3× | 9.8×+0.7× | 9.8×+0.9× | 9.8×+1.4× | 9.4×+1.0× | |
| Free cash flow yield | 25.8%+3.1pp | 25.3%+1.8pp | 23.7%0.0pp | 23%+0.9pp | 22.7%+0.8pp | |
| Earnings yield | 19.2%-1.2pp | 19.2%-2.1pp | 19.2%-2.4pp | 19.5%-2.8pp | 20.3%-1.5pp | |
| Dividend yield | 6.8%-1.0pp | 6.9%-1.2pp | 7.1%-1.1pp | 7.4%-1.2pp | 7.8%-0.6pp | |
| PEG ratio | 5.9×-12.4× | 7.9×-9.5× | 16.2×— | 16.8×— | 18.3×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Quest Diagnostics's profit margins?
- Quest Diagnostics (DGX) runs a 33.2% gross margin and a 14.3% operating margin, with a 9.1% net margin.
- Where do Quest Diagnostics's ratios come from?
- Every ratio is computed from Quest Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
